2018 Live Webinar
Microbiome-Directed Therapeutics To Tackle Metabolic Disorders
Hosted by Sandrine Claus, Chief Scientific Officer, LNC Therapeutics
Thursday 5th April 2018 | 2pm GMT
Can’t make the dates? Still register and receive the recording afterwards
- Why microbiome-directed therapeutics are interesting therapeutic agents to address metabolic disorders associated with gut microbial dysbiosis
- The promise and limitatations of microbiome-directed therapeutics
![]() | Sandrine Claus is Associate Professor in Integrative Metabolism at the University of Reading. She obtained her PhD in Biochemistry at Imperial College London, where she started to study host – gut microbiota metabolic interplays. Her current research focuses on understanding the biological mechanisms underpinning the relationship between gut microbial ecology and host metabolism in health and disease. She is a key member of MyNewGut, a large EU-funded consortium investigating the role of gut microbiota on the development of obesity and associated alterations of cognition. She acts as associate editor for the journal Microbial Ecology in Health and Disease. She joined LNC Therapeutics as Chief Scientific Officer in 2017. |
Who Should Attend This Webinar?
Our free webinar is for microbiome discovery and development experts interested in learning more about the latest work in the field. This is a free event open to all, so why not register and benefit from the expertise of our speakers?
Follow us on